GENE ONLINE|News &
Opinion
Blog

2025-03-20|

NICE Approves First-Ever Daily Pill for Endometriosis Treatment

by Bernice Lottering
Share To
Ryeqo is the first long-term daily pill to treat endometriosis has been recommended for routine NHS use in England. Image: Shutterstock.
The National Institute for Health and Care Excellence (NICE) has approved relugolix combination therapy, which can be taken at home instead of requiring regular injections. Now available through the NHS in England and Wales, this first-ever daily pill for treating endometriosis symptoms, offers a new option for patients who have exhausted all other treatments. Around … NICE Approves First-Ever Daily Pill for Endometriosis Treatment Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Phosphorylation and Ubiquitination Mechanisms Linked to Rosacea Pathogenesis
2026-10-10
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
READ MORE
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
2026-10-27
ESGCT 2026 (Gene & Cell Therapy)
Hamburg, Germany
2026-11-09
BIO-Europe 2026 (Partnering & Dealmaking)
Cologne, Germany
2026-11-15
HLTH 2026 (Nov 15–18, Las Vegas) (Healthcare innovation)
Las Vegas, Nevada
2026-11-16
MEDICA 2026 (Global Medtech)
Düsseldorf, Germany
SEE MORE
Scroll to Top